Celularity Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Celularity Inc. (CELU) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $2.77 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2021-08-19
- Celularity Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-06-30 was $1.14M.
- Celularity Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-03-31 was $1.63M.
- Celularity Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2020-12-31 was $3.35M, a 3140.19% increase year-over-year.
- Celularity Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2020-09-30 was $11.29K, a 77.76% decline year-over-year.
- Celularity Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2020 was $3.20M, a 1426.15% increase from fiscal 2019.
- Celularity Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2019 was $209.66K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 4 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2021-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-19 | $2.77M 10-Q · filed 2021-08-19 | $6.12M derived: sum of 3 quarters · filed 2021-08-19 | $6.13M derived: sum of 4 quarters · filed 2021-08-19 | |
| 2021-03-31 | $1.63M 10-Q · filed 2021-05-24 | $4.98M derived: sum of 2 quarters · filed 2021-05-24 | $4.99M derived: sum of 3 quarters · filed 2021-05-24 | $4.97M derived: sum of 4 quarters · filed 2021-08-19 | |
| 2020-12-31 | $3.35M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | $3.36M derived: sum of 2 quarters · filed 2021-05-24 | $3.34M derived: sum of 3 quarters · filed 2021-08-19 | $3.20M 10-K/A · filed 2021-05-24 | |
| 2020-09-30 | $11.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$6.99K derived: sum of 2 quarters · filed 2021-08-19 | -$150.60K 10-Q · filed 2020-11-16 | -$47.20K derived: sum of 4 quarters · filed 2021-08-19 | |
| 2020-06-30 | -$18.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-19 | -$161.89K 10-Q · filed 2021-08-19 | -$58.49K derived: sum of 3 quarters · filed 2021-08-19 | -$7.73K derived: sum of 4 quarters · filed 2021-08-19 | |
| 2020-03-31 | -$143.61K 10-Q · filed 2021-05-24 | -$40.21K derived: sum of 2 quarters · filed 2021-05-24 | $10.55K derived: sum of 3 quarters · filed 2021-05-24 | $66.60K derived: sum of 4 quarters · filed 2021-05-24 | |
| 2019-12-31 | $103.40K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | $154.15K derived: sum of 2 quarters · filed 2021-05-24 | $210.21K derived: sum of 3 quarters · filed 2021-05-24 | $209.66K 10-K/A · filed 2021-05-24 | |
| 2019-09-30 | $50.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $106.81K derived: sum of 2 quarters · filed 2020-11-16 | $106.26K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $56.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $55.50K 10-Q · filed 2020-08-13 | |||
| 2019-03-31 | -$555.00 10-Q · filed 2020-05-15 | ||||
| 2018-12-31 | $555.00 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |